You are here: Industry Insights > Europe

News List

U.S. Travelers Should Be Aware of Measles Risk in Europe drugs
June 18, 2019
U.S. Travelers Should Be Aware of Measles Risk in Europe.
Waylivra granted conditional marketing authorisation in Europe pharmatimes
May 09, 2019
Waylivra granted conditional marketing authorisation in Europe.
Sensitive blood tests diagnose heart attacks sooner than conventional methods europeanpharmaceuticalreview
April 22, 2019
The ‘new’ test is one currently used in Europe, however the US Food and Drug Administration have recently given approval for the high-sensitivity troponin test…
Europe-Africa partnership spearheads development of next-generation antimalarial drug europeanpharmaceuticalreview
April 19, 2019
The grant will support African trials of a novel antimalarial combination comprising KAF156 (ganaplacide) and lumefantrine in a new once-daily formulation…
SPC manufacturing waiver is good news for Europe europeanpharmaceuticalreview
April 18, 2019
An SPC manufacturing waiver should be extremely beneficial for Europe and will increase net sales of the EU pharmaceutical industry…
Europe approves Lynparza in HER2-, gBRCAm advanced breast cancer pharmafile
April 11, 2019
Lynparza (olparib), the poly ADP ribose polymerase (PARP) inhibitor developed by AstraZeneca and MSD, has been awarded marketing approval by the European Commission...
Moberg Pharma and Bayer Sign Exclusive License Agreement for MOB-015 in Europe pharmafocusasia
February 14, 2019
Moberg Pharma has entered into a license agreement granting the Consumer Health division of Bayer exclusive European rights to MOB-015.....
Medicines for Europe Welcomes Competitiveness Council Discussion to Stop Delocalisation of Medicines Manufacturing. It is Time to Effectively Position Europe as a Global Hub for the Production of Medicines firstwordpharma
December 02, 2018
Yesterday, 29th November, members of the Competitiveness Council expressed strong support for an SPC manufacturing waiver. While we regret that a couple of countries are clearly supporting vested interests in their complete opposition to the waiver, at le
Europe's biggest private biotech company raises $270 million biospectrumasia
November 29, 2018
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to support its work in developing personalized immunotherapies for cancer...
Agreement with Grünenthal for rights to Nexium in Europe and Vimovo worldwide (ex-US) worldpharmanews
October 31, 2018
AstraZeneca has agreed to divest the prescription medicine rights to Nexium (esomeprazole) in Europe, as well as the global rights (excluding the US and Japan) to Vimovo (naproxen/esomeprazole) to Grünenthal.

Previous page 1 2 3 4 5 Next page